Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 8OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1

Conditions

Peritoneal Neoplasms 1Pancreatic Neoplasms 1Neoplasms 1Neoplasm Metastasis 1

Interventions

Capecitabine 9Bevacizumab 8tislelizumab 7Oxaliplatin 7Drug Therapy 7pembrolizumab 6Surgical Procedures, Operative 6Standard of Care 6Cisplatin 6Radiotherapy 5Laparoscopy 5Fluorouracil 5Docetaxel 5Carboplatin 5Radiosurgery 4Leucovorin 4Exercise 4Epirubicin 4Cyclophosphamide 4toripalimab 3pertuzumab 3durvalumab 3dalpiciclib 3atezolizumab 3anlotinib 3Saline Solution 3Rituximab 3Prednisone 3Population Groups 3Observation 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER_GOV × Pancreatectomy × 1 year × Clear all
NCT07493421 2026-03-25

To Evaluate the Feasibility and Safety of Combining Surgery (Pancreatectomy and Cytoreduction) With HIPEC for Treating Pancreatic Cancer With Peritoneal Involvement.

Unidade Local de Saúde São João

Phase NA Recruiting
20 enrolled
GastrointestinalGynecologic

Neoplasm Metastasis, Neoplasms, Pancreatic Neoplasms, Peritoneal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡